Published: 7 March 2019
Publications
Recent approvals of medicines containing a new active ingredient
Prescriber Update 40(1): 15
March 2019
For the period 16 October 2018 to 15 January 2019.
| Trade name (Active ingredient) | Dose form and strength(s) | Therapeutic area |
|---|---|---|
| Adynovate (rurioctocog alfa pegol) | Powder for injection 250 IU 500 IU 1000 IU 2000 IU |
Haemophilia A (congenital factor VIII deficiency) |
| Kyprolis (carfilzomib) | Powder for infusion 30 mg 60 mg |
Multiple myeloma |
See the Medsafe website for more information about these medicines (www.medsafe.govt.nz/regulatory/DbSearch.asp).
Data sheets of currently marketed medicines are also available (www.medsafe.govt.nz/Medicines/infoSearch.asp).
